Co-Diagnostics anticipates filing FDA 510(k) in the third quarter as CoSara expands TAM to approximately $13B

Centuri appoints Kelly Youngblood as CFO

2026/08/12

PulteGroup enters repurchase pact to finance mortgage originations

2026/08/12

Tevano Systems appoints David Bajwa as CEO and interim CFO

2026/08/12

Securitize Q2 earnings shock: Revenue miss, wider loss sends stock tumbling

2026/08/12